Upgrade to SI Premium - Free Trial

Jefferies on United Therapeutics Corp. (UTHR): expecting '+15–25%' move following positive topline data

March 30, 2026 8:11 AM
Jefferies analyst Roger Song reiterated a Buy rating and ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments

Next Articles